Stemline Therapeutics Inc - 10022 New York City, NY

Business Name: Stemline Therapeutics Inc
Categorized In:
Address: 750 Lexington Avenue Floor 6, New York City, NY 10022
Phone Number: (646) 502-2310
Contact Person: Ivan Bergstein, Chief Executive Officer
Website Address: stemline.com
NAICS Code: 3254120
SIC Code: 2834
Business Type: B2B & B2C
Founding Year: 2003
Employee #: 1 to 4
Location Type: Headquarters
Annual Revenue ($): Unknown
Share This Business:
Similar Businesses: Lightlake Therapeutics Inc - New York City, NY 10022
Krele LLC - New York City, NY 10022
Melinta Pharmaceuticals Inc - New York City, NY 10022
Aoi Pharma Inc - New York City, NY 10022
Niobe Ventures LLC - New York City, NY 10022
Ohr Pharmaceutical Inc - New York City, NY 10022
Bristol-Myers Squibb Company - New York City, NY 10022
Forest Laboratories Inc - New York City, NY 10022
Keryx Biopharmaceuticals Inc - New York City, NY 10022
Tonix Pharmaceuticals Inc - New York City, NY 10022
Danube Pharmaceuticals Inc - New York City, NY 10022

Stemline Therapeutics Inc provides professional from its headquarters at the coordinates 40.762509,-73.968061.

The company offers BOTH variables under the SIC code 2834 and NAICS code 3254120, while making an annual revenue of Unknown and hiring a total of 1 to 4 employees.

Founded in 2003, the company can now be visited at 750 Lexington Avenue Floor 6, New York City, New York 10022 or contacted through representative Ivan Bergstein, Chief Executive Officer at (646) 502-2310.

For frequently asked questions and further inquiries about professional , get to know more about Stemline Therapeutics Inc through its company website at stemline.com. Engage with this business on its social media platforms through on Twitter and on Facebook.